[由内在因子抗体干扰引起的虚假正常维生素B12水平的恶性贫血:病例报告]
Wiame Ghammad1, Aurélie Sarthou1, Marion Dutkiewicz1
1Service d'Hématologie biologique, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France.
Annales de biologie clinique
|November 21, 2023
概括
由于自抗体对维生素B12检测的干扰,恶性贫血的诊断可能具有挑战性. 这一案例凸显了为准确评估可巴拉胺水平而需要标准化测试方法的必要性.
科学领域:
- 临床医学 临床医学
- 血液学 血液学 血液学
- 临床化学 临床化学
背景情况:
- 宏细胞贫血和血小板缺血可以呈现出正常的血清维生素B12水平.
- 高水平的同类氨酸和甲基马龙酸,以及骨髓异质化,尽管进行了正常的维生素B12测定,但暗示着科巴拉缺乏.
- 恶性贫血是一种影响维生素B12吸收的自身免疫性疾病.
研究的目的:
- 报告一种患有恶性贫血的病例,与维生素B12测试干扰相关的诊断挑战.
- 研究自身抗体对维生素B12测量技术的影响.
- 为了强调测试标准化在诊断维生素B12缺乏障碍中的重要性.
主要方法:
- 一个48岁的妇女患有宏细胞性贫血和血小板缺血的案例介绍.
- 使用了标准实验室检测,包括血清叶酸,维生素B12,同类半氨酸和甲基马龙酸.
- 雇员骨髓吸取物用于形态评估.
- 使用竞争性结合化学发光 (CBLA) 和电化学发光进行了连续维生素B12测定.
- 对抗内在因子抗体进行了测试,并进行了免疫球蛋白吸附研究.
主要成果:
- 最初的维生素B12水平正常,但间接标志物表明缺乏.
- 检测到高水平的抗内在因子抗体,导致CBLA测定干扰.
- 通过电化学发光测量的维生素B12水平明显较低.
- 免疫球蛋白吸附证实自抗体干扰与科巴胺试验.
结论:
- 自体抗体,特别是抗内在因子抗体,可以干扰标准维生素B12测定,导致不准确的结果.
- 准确诊断恶性贫血需要仔细考虑测试方法和潜在干扰.
- 维生素B12测定标准化对于可靠的诊断和治疗科巴拉明缺乏症至关重要.
更多相关视频
相关概念视频
Gastritis-II: Pathophysiology
346
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
346
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
337
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
337
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Disorders of Hemostasis
945
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
945
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
436
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
436
Inflammatory Bowel Disease I: Ulcerative Colitis
190
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
190


